These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34128075)

  • 21. Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.
    Lindholm CJ; Fredholm O; Möller SJ; Edvardsson N; Kronvall T; Pettersson T; Firsovaite V; Roijer A; Meurling CJ; Platonov PG; Olsson SB
    Heart; 2004 May; 90(5):534-8. PubMed ID: 15084552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary vein flow analysis by transoesophageal echocardiogr phy in patients with chronic atrial fibrillation; 1 year follow-up after cardioversion.
    Paraskevaidis IA; Theodorakis GN; Katritsis DG; Tsiapras DP; Livanis EG; Kremastinos DT
    Eur Heart J; 1999 Mar; 20(5):375-85. PubMed ID: 10206384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antithrombotic therapy in patients with atrial flutter before planned cardioversion].
    М'якінькова ЛО; Тесленко ЮВ; Пустовойт ГЛ; Ярмола ТІ; Циганенко ІВ
    Wiad Lek; 2016; 69(6):742-746. PubMed ID: 28214808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of maintenance of sinus rhythm after cardioversion of atrial fibrillation by analysis of serial signal-averaged P waves.
    Stafford PJ; Kamalvand K; Tan K; Vincent R; Sulke N
    Pacing Clin Electrophysiol; 1998 Jul; 21(7):1387-95. PubMed ID: 9670182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin.
    Akdeniz B; Türker S; Oztürk V; Badak O; Okan T; Aslan O; Kozan O; Kirimli O; Aytekin D; Bariş N; Güneri S
    Int J Cardiol; 2005 Jan; 98(1):49-55. PubMed ID: 15676166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disappointing Success of Electrical Cardioversion for New-Onset Atrial Fibrillation in Cardiosurgical ICU Patients.
    Arrigo M; Jaeger N; Seifert B; Spahn DR; Bettex D; Rudiger A
    Crit Care Med; 2015 Nov; 43(11):2354-9. PubMed ID: 26468695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
    Renda G; Zimarino M; Ricci F; Piccini JP; Ezekowitz MD; Patel MR; Cappato R; Giugliano RP; De Caterina R
    Am J Med; 2016 Oct; 129(10):1117-1123.e2. PubMed ID: 27262782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
    Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
    Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
    de Luca I; Sorino M; Del Salvatore B; de Luca L
    Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].
    Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M
    Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
    Nairooz R; Sardar P; Pino M; Aronow WS; Sewani A; Mukherjee D; Paydak H; Maskoun W
    Int J Cardiol; 2015; 187():345-53. PubMed ID: 25839640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Edvardsson N; Rosenqvist M
    Heart; 2009 Jun; 95(12):1000-5. PubMed ID: 19304669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year.
    Weigner MJ; Thomas LR; Patel U; Schwartz JG; Burger AJ; Douglas PS; Silverman DI; Manning WJ
    Am J Med; 2001 Jun; 110(9):694-702. PubMed ID: 11403753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
    Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
    G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up.
    Gasparini G; Bonso A; Themistoclakis S; Giada F; Raviele A
    Europace; 2001 Apr; 3(2):90-5. PubMed ID: 11333060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.
    Falsetti L; Viticchi G; Tarquinio N; Silvestrini M; Capeci W; Balloni A; Catozzo V; Gentile A; Pellegrini F
    J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):636-41. PubMed ID: 24978663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial.
    Stiell IG; Sivilotti MLA; Taljaard M; Birnie D; Vadeboncoeur A; Hohl CM; McRae AD; Rowe BH; Brison RJ; Thiruganasambandamoorthy V; Macle L; Borgundvaag B; Morris J; Mercier E; Clement CM; Brinkhurst J; Sheehan C; Brown E; Nemnom MJ; Wells GA; Perry JJ
    Lancet; 2020 Feb; 395(10221):339-349. PubMed ID: 32007169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.